Tarsus Pharmaceuticals (TARS)
(Delayed Data from NSDQ)
$33.89 USD
+1.62 (5.02%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $33.89 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Tarsus Pharmaceuticals, Inc. (TARS) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$57.00 | $67.00 | $30.00 | 76.63% |
Price Target
Based on short-term price targets offered by eight analysts, the average price target for Tarsus Pharmaceuticals, Inc. comes to $57.00. The forecasts range from a low of $30.00 to a high of $67.00. The average price target represents an increase of 76.63% from the last closing price of $32.27.
Analyst Price Targets (8 )
Broker Rating
Tarsus Pharmaceuticals, Inc. currently has an average brokerage recommendation (ABR) of 1.22 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 1.22 a month ago based on nine recommendations.
Of the nine recommendations deriving the current ABR, eight are Strong Buy, representing 88.89% of all recommendations. A month ago, Strong Buy represented 88.89%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 8 | 8 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.22 | 1.22 | 1.22 | 1.22 | 1.22 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/30/2024 | William Blair | Lachlan Hanbury-Brown | Not Available | Strong Buy |
8/9/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/13/2024 | H.C. Wainwright & Co. | Oren Livnat | Strong Buy | Strong Buy |
5/10/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/9/2024 | LifeSci Capital | Cory Jubinville | Strong Buy | Strong Buy |
2/29/2024 | Goldman Sachs | Andrea Tan | Hold | Hold |
2/27/2024 | Guggenheim Securities | Eddie Hickman | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.22 |
ABR (Last week) | 1.22 |
# of Recs in ABR | 9 |
Average Target Price | $57.00 |
LT Growth Rate | 27.80% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 83 of 252 |
Current Quarter EPS Est: | -0.89 |
TARS FAQs
Tarsus Pharmaceuticals, Inc. (TARS) currently has an average brokerage recommendation (ABR) of 1.22 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 9 brokerage firms.
The average price target for Tarsus Pharmaceuticals, Inc. (TARS) is $57.00. The current on short-term price targets is based on 6 reports.
The forecasts for Tarsus Pharmaceuticals, Inc. (TARS) range from a low of $30 to a high of $67. The average price target represents a increase of $68.19 from the last closing price of $33.89.
The current UPSIDE for Tarsus Pharmaceuticals, Inc. (TARS) is 68.19%
Based on short-term price targets offered by eight analysts, the average price target for Tarsus Pharmaceuticals, Inc. comes to $57.00. The forecasts range from a low of $30.00 to a high of $67.00. The average price target represents an increase of 76.63% from the last closing price of $32.27.